SPRC — SciSparc Ltd. Ordinary Shares
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: IL
- Exchange: NASDAQ
- Employees: 3
- Website: https://www.scisparc.com
Latest SEC filings for SPRC
- 6-K — 2026-10-23
- 6-K — 2026-10-15
- 6-K — 2026-10-15
- 6-K — 2026-10-07
- 6-K — 2026-09-30
- 6-K — 2026-09-24
- 6-K — 2026-09-02
- EFFECT — 2026-09-01
- 6-K — 2026-08-24
- 20-F/A — 2026-08-19
Latest SPRC news
- — EARNINGS_CALL_TRANSCRIPT_TITLE_FORMATTED - Yahoo Finance (Yahoo Finance)
- — SciSparc Ltd. (SPRC) stock price, news, quote and history - Yahoo Finance UK (Yahoo Finance UK)
- — Thursday's after hours session: top gainers and losers - ChartMill (ChartMill)
- — U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.08% - Investing.com (Investing.com)
- — United States shares higher at close of trade; Dow Jones Industrial Average up 1.08% - Investing.com India (Investing.com India)
- — SPRC 6-K & SEC Filings - Yahoo Finance - Yahoo (Yahoo)
- — No cash would flow to SciSparc (SPRC) under a proposed debt-for-shares conversion. - Stock Titan (Stock Titan)
- — 12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga (Benzinga)
- — SciSparc Jumps as Investors React to NeuroThera’s Quantum-Analysis Update - Quiver Quantitative (Quiver Quantitative)
- — Drug developer SciSparc (SPRC) plans to evaluate AI companies and technologies. - Stock Titan (Stock Titan)
Educational tool only — not investment advice.